Literature DB >> 26915452

Lung disease: CXCR7 activation overrides lung fibrosis.

Megan Cully.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26915452     DOI： 10.1038/nrd.2016.25

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  2 in total

Review 1.  Targeting vascular and leukocyte communication in angiogenesis, inflammation and fibrosis.

Authors:  Johan Kreuger; Mia Phillipson
Journal:  Nat Rev Drug Discov       Date:  2015-11-27       Impact factor: 84.694

2.  Targeting of the pulmonary capillary vascular niche promotes lung alveolar repair and ameliorates fibrosis.

Authors:  Zhongwei Cao; Raphael Lis; Michael Ginsberg; Deebly Chavez; Koji Shido; Sina Y Rabbany; Guo-Hua Fong; Thomas P Sakmar; Shahin Rafii; Bi-Sen Ding
Journal:  Nat Med       Date:  2016-01-18       Impact factor: 53.440
  2 in total
  2 in total

1.  Discovery of Amantamide, a Selective CXCR7 Agonist from Marine Cyanobacteria.

Authors:  Xiao Liang; Danmeng Luo; Jia-Lei Yan; Mohammad A Rezaei; Lilibeth A Salvador-Reyes; Sarath P Gunasekera; Chenglong Li; Tao Ye; Valerie J Paul; Hendrik Luesch
Journal:  Org Lett       Date:  2019-02-19       Impact factor: 6.005

Review 2.  Irreversibility of Pulmonary Fibrosis.

Authors:  Qing Yang Yu; Xiao Xiao Tang
Journal:  Aging Dis       Date:  2022-02-01       Impact factor: 6.745
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.